Drug intelligence / Profile preview

bacoside A

Development stage
Preclinical
Modality
Small Molecules
Administration
Oral
01

Overview

**Bacoside A** is a mixture of dammarane-type triterpenoid saponins and is the principal bioactive constituent of *Bacopa monnieri* (Brahmi), an herb used in traditional medicine for cognitive enhancement and neuroprotection[1][2][5]. Chemically, bacoside A encompasses four saponins: bacoside A3, bacopaside II, jujubogenin isomer of bacopasaponin C (bacopaside X), and bacopasaponin C[1][5]. Its mechanism of action includes antioxidant and membrane-stabilizing effects, prevention of lipid peroxidation, upregulation of antioxidant enzymes, and stabilization of neuronal membranes[1]. It regulates mRNA translation and surface expression of neuroreceptors such as AMPA, NMDA, and GABA receptors in the brain[1]. Experimental evidence shows bacoside A inhibits cytotoxicity and fibrillation of amyloid-beta (Aβ42), potentially ameliorating Alzheimer's disease pathology[3]. Some studies also indicate interaction with dopamine D1 receptors[5].

Other names
Bacoside A11028-00-5Bacoside A-RMBacoside A (Mixture)BACOSIDE A(SH)BACOSIDE A(MIXTURE OF SAPONINS)Dammar-24-en-16-one,3-[(O-R-Larabinopyranosyl-β3-[(O-alpha-L-Arabinopyranosyl-beta-D-glucopyranosyl)oxy]-19,20-dihydroxydammar-24-en-16-one
02

Targets

PPARG (Peroxisome proliferator-activated receptor gamma)Aβo–PrPC (Amyloid-β oligomer–cellular prion protein interface)MAOB (Monoamine oxidase B)MAOA (Monoamine oxidase A)CAMK2A (Calcium/calmodulin-dependent protein kinase II alpha)DRD1 (Dopamine D1 Receptor)

Beyond the preview

Go deeper on bacoside A.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on bacoside A.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call